Video Interview: Smart for Life (SMFL) CEO A.J. Cervantes.
Excellent interview. We were at the Noble Investor Conference to see it live. And we were at the manufacturing plant this Friday....
Smart For Life to Present at The Noble Capital Markets Eighteenth Annual Investor Conference.
MIAMI, April 14, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leading...
Adding Smart for Life (SMFL) $0.85 to the Watch List.
Adding another "Broken" IPO to the Watch List.
We're not sure if "broken" is the appropriate description, when...
Billion Dollar Aggregators Buying Mom-and-Pop Amazon Sellers. Simply Amazing.
At least 77 Amazon aggregators have raised roughly $10 billion in total since April 2020, according to Marketplace Pulse.
OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.
Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share.
Without disrupting legacy sales - CEO Shai...
OMNIQ (OMQS) to Begin Trading on NASDAQ
100% Here, 100% There, Pretty Soon it all Adds up. Our Sixth Client to Graduate to NASDAQ.
Yes, some...
With Hapbee (HAPBF) Who Needs, Drugs, Caffeine or Nicotine?
Record 1 Million Hours of Mood Stimulation Served by Hapbee (HAPBF).
TRADING AT THE LOWER END OF...
Aphex BioCleanse Further Expands Distribution Channels.
Aphex BioCleanse Systems Announces Partnership With Bifulco Consulting Group to Expand Distribution Channels
PITTSFORD, N.Y., May 20, 2021...
Two of Our $5.00 Watch List Stocks Double, in Like Just Five Months!
Added to the Watch List in November, OMNIQ (OMQS) and Galaxy Digital (GLXY) Shine like a Pretty Penny, with OMNIQ Doubling...
OMNIQ (OMQS) $10.00, Announces Record $25 Million in New Orders, 100% Growth in AI-Based...
OMNIQ Announces Q4 2020 Revenue, up 12% YoY achieving $13 Million in Q4 Revenue; Growth Accelerates in Q1 2021 with a...
Latest article
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...
